Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Celeste Lebbe
Based on 101 articles published since 2007
||||
Expertise Level
The expertise of Celeste Lebbe ranks in the
  • Top 0.051%
  • ... of 104,046 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 101 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Lebbe, C   ·   Lebbé, C   ·   Lebbé, Celeste   ·   Lebbé, Céleste   ·   Lebbe, Céleste   ·   Lebbe, Celeste
Work Locations
Details
Most likely:    Universite Paris 7 Diderot      
2017
  • Université Paris-Diderot, Sorbonne-Paris-Cité, APHP services de dermatologie et CIC, hôpital Saint-Louis-Paris, INSERM U976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Département de médecine, service de dermatologie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris-Sud, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28063593
  • AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Diabetology Department, Lariboisière Hospital, Paris, France. · INSERM U1138, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Pharmacology Department, Saint-Louis Hospital, Paris, France. · AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, Paris, France. · AP-HP Hormonology Department, Saint-Louis Hospital, Paris, France. · Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · Pubmed 28634815
  • Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, T2-041, Toronto, ON, M4N 3M5, Canada. Electronic address: · Gustave Roussy and Université Paris-Sud, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Medical University of Graz, Auenbruggerpl. 2, 8036 Graz, Graz, Austria. Electronic address: · Segal Cancer Centre, Jewish General Hospital, Rossy Cancer Network, and McGill University, 3755 Ch de la Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, Canada. Electronic address: · Karolinska Institute, Solnavägen 1, 171 77 Solna, Stockholm, Sweden. Electronic address: · Princess Alexandra Hospital and The University of Queensland, 199 Ipswich Rd, Woolloongabba, Brisbane, QLD 4102, Australia. Electronic address: · APHP, Dermatology and CIC, Université Paris Diderot, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France. Electronic address: · Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham B15 2TH, UK. Electronic address: · The Churchill Hospital and The University of Oxford, Old Rd, Headington, Oxford OX3 7LE, UK. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, La Trobe University, 145 Studley Road, Heidelberg VIC 3084, Melbourne, Australia. Electronic address: · Pubmed 28987768
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. Electronic address: · Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pharmacy, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Nuclear Medecine Unit, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Rheumatology Department, INSERM UMR 1132, Lariboisière Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pubmed 28438383
  • Department of Dermatology, Medical Faculty, Military Medical Academy, Belgrade, Serbia. · Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. · National and Kapodistrian University of Athens, Greece. · Service de Dermatologie et Cancérologie Cutanée, Hopital de la Timone, Marseille, France. · Mount Vernon Cancer Centre, Northwood, United Kingdom. · UniversitätsSpital Zürich-Skin Cancer Center, University Hospital, Zürich, Switzerland. · Carol Davila University of Medicine and Pharmacy, Elias University Hospital Bucharest, Romania. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · NN Blokhin Russian Cancer Research Center, Moscow, Russia. · APHP Hospital Saint Louis, Paris, France. · Netherland Cancer Institute, Amsterdam, Netherlands. · Department of Dermatology and Allergology, University of Szeged, Hungary. · Department of Oncology, Odense University Hospital, Denmark. · Department of Oncology, University Hospital Zagreb, Croatia. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium. · Department of Dermatology, Medical Faculty, University of Coimbra, Portugal. · Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden. · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland. · General Teaching Hospital, Prague, Czech Republic. · Department of Dermatology, Vilnius University, Lithuania. · Division of Dermatology and Venerology, Medical University of Graz, Graz, Austria. · University Hospital Center Sestre Milosrdnice, Zagreb, Croatia. · Institute of Oncology and Radiology of Serbia, Belgrade, Serbia. · Department of Oncology, University Hospital Sarajevo, Bosnia and Herzegovina. · North Estonia Medical Centre, Tallinn, Estonia. · Department of Dermatology & Venerology & Allergy, Medical University Innsbruck, Austria. · Clinic for Oncology and Radiotherapy, Podgorica, Montenegro. · Clinic of Oncodermatology, National Cancer Center, Sofia, Bulgaria. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · N.N. Alexandrov National Cancer Сenter of Belarus (NCCB), Minsk, Belarus. · National Cancer Institute, Kiev, Ukraine. · Department of Clinical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain. · University Hospital Mother Theresa, Tirana, Albania. · University Clinic of Radiotherapy and Oncology, Skopje, Former Yugoslav Republic of Macedonia. · Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · Pubmed 28264791
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2016
  • Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK. Electronic address: · Servicio de Dermatología, Hospital Clínic de Barcelona, Catalonia, Spain. · Assistance Publique - Hôpitaux de Paris (AP-HP) Hôpital Saint-Louis, Dermatology Department Université Paris-Diderot, Sorbonne Paris Cité, INSERM UMR-S 976, Paris, France. · Adelphi Values, Bollington, UK. · Amgen Ltd., Uxbridge, London UK. · Amgen GmbH, Zug, Switzerland. · Klinik für Dermatologie, Universitätsklinikum Essen, Essen, Germany. · Pubmed 27118416
  • Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France. Electronic address: · Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France. · Pubmed 26944639
  • Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud 75005, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Versailles 78000, France. · CHU de Nantes-Hôtel Dieu, Nantes 44093, France. · Radiotherapy Department, Institut Curie, Paris 75005, France. · La Timone Hospital-APHM, Aix-Marseille University, Marseille 13385, France. · Dermatology department, Saint-André Hospital, CHU de Bordeaux, Bordeaux 33000, France. · Lyon Sud Hospital Center, Lyon 1 University, Pierre Benite 69495, France. · Saint-Louis Hospital, APHP, Paris 75010, France. · Dermatology department, CHRU of Lille, Lille 59037, France. · Ambroise Paré Hospital, Boulogne Billancourt 92104, France. · Cochin hospital, APHP, Paris 75014, France. · Bichat Hospital, Paris 75877, France. · CHU Rouen, Charles-Nicolle, Rouen 76000, France. · Institut Curie, Paris 75005, France. · DNA Therapeutics, Evry 91058, France. · Department of Biostatistics, Institut Curie, Paris 75005, France. · Institut Curie, Orsay 91405, France. · CNRS-UMR3347, INSERM-U1021, Paris-Sud University, Orsay 91405, France. · Pubmed 27140316
  • INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France; Inserm UMRS-1131, Institut Universitaire d'Hématologie, Paris, France. · Centre d'Epidémiologie Clinique, Hôtel-Dieu, AP-HP, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; INSERM, UMR 1153, Centre de Recherche Epidémiologie et Statistique (CRESS), Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France. · Service de Dermatologie, Hôpital Xavier Bichat, AP-HP, Paris, France. · Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France; INSERM UMR-976, Hôpital Saint-Louis, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 27728898
  • Kantar Health, Paris, France. · Amgen, Centre for Observational Research, Uxbridge, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. · APHP Dermatology and CIC Hospital Saint Louis University Paris 7, INSERM U976, Paris, France. · Department of Dermatology, University Hospital Duisburg-Essen, Essen, Germany. · Pubmed 27628317
  • Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Dermatology Unit, Hospices Civils de Lyon CH Lyon Sud, Pierre Bénite Cedex, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Department of Biopathology, Centre Léon Bérard, Lyon, France. · Department of Biopathology, Hospices Civils de Lyon CH Lyon Sud, Pierre-Bénite Cedex, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · INSERM U1065 Equipe 1 Biologie et pathologies des mélanocytes: de la pigmentation cutanée au mélanome Equipe labellisée Ligue 2013 Centre Méditerranéen de Médecine Moléculaire, Nice, France Université de Nice Sophia-Antipolis UFR Médecine, Nice, France CHU Nice Service de Dermatologie, Nice, France. · APHP INSERM U976 Saint Louis Hospital Pharmacology-Genetic Laboratory Paris, Paris, France. · Department of Pathology, INSERM U1165 Université Paris Diderot AP-HP Hôpital Saint-Louis, Paris, France. · Department of Dermatology, APHP Saint Louis Hospital, Paris, France INSERM U976 University Paris 7 Diderot, Paris, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Institut Universitaire de France, Paris, France · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France · Pubmed 27596438
  • Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. Electronic address: · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Clinical Investigation Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Nuclear Medicine Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Pathology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Plastic Surgery Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Onco-Dermatology, Immunology and Cutaneous Stem Cells, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pneumology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Biostatistics and Clinical Epidemiology research team, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Clinical Investigation Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Onco-Dermatology, Immunology and Cutaneous Stem Cells, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 27157227
  • Inserm U 976, Paris, France. · Inserm U 1165, Paris, France. · Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Department of Pathology, AP-HP, Hôpital Saint-Louis, Paris, France. · INSERM, IAME, UMR 1137, Paris, France. · Department of Biochemistry, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of plastic surgery, AP-HP, Hôpital Saint-Louis, Paris, France. · EA4340, Versailles University, Boulogne-Billancourt, France. · AP-HP, Ambroise Paré Hospital, Department of Dermatology, Boulogne-Billancourt, France. · AP-HP, Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, Paris, France. · Laboratoire CRRET, CNRS-UMR 7149, Créteil, France. · Université Paris 12, Créteil, France. · Pubmed 27060463
  • Dermatology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Nephrology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Physiology Department, DHU Fire, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Biostatistic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, ECSTRA Team, Inserm UMR-1153, Université Paris 7 Diderot, Paris, France. · Biochemistry Department, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Pharmacology and Genetic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Inserm Unit 976, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 26930506
  • INSERM UMR_S976, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Dermatology, Paris, F-75010, France. · Université Paris-Diderot, Sorbonne Paris Cité, Paris, F-75013, France. · INSERM UMR_S1165, Paris, F-75010, France. · Université Paris-Diderot, Department of Pathology, UMR_S1165, Paris, F-75010, France. · UMR CNRS 8612, Institut Galien-UFR de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, F-92290, France. · INSERM UMR_1137, Paris, F-75018, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie Biologique, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Plastic, Reconstructive and Esthetic Surgery, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Pathology, Paris, F-75010, France. · Pubmed 26909610
  • Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris · Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris. · INSERM, IAME, UMR 1137, Université Paris Diderot, Paris. · Deparment of Pharmacy, AP-HP, Saint-Louis Hospital, Paris, France. · Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris. · Pubmed 26578723
2015
  • AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 25965357
  • Neuro-oncologie, département de neurochirurgie, hôpital Roger-Salengro, CHRU, rue Émile-Laine, 59037 Lille cedex, France; Oncologie médicale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France; Inserm U1192, laboratoire Prism, université Lille 1, bâtiment SN3 1(er) étage, 59655 Villeneuve-d'Ascq cedex, France; Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France. Electronic address: · Département de dermatologie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de dermatologie, centre hospitalier régional et universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département de radiothérapie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France; Réunion de concertation pluridisciplinaire de neuro-oncologie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de dermatologie, centre hospitalier universitaire, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Université Montpellier 1, 5, boulevard Henri-IV, CS 19044, 34967 Montpellier cedex 2, France. · Département de dermatologie, centre hospitalo-universitaire, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France. · Département de dermatologie, hôpital Saint-Louis, Assistance publique-Hôpitaux de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Service de dermatologie, pôle d'oncologie-radiothérapie, de dermatologie et des soins palliatifs, groupe hospitalier Saint-André, centre hospitalier universitaire de Bordeaux, 1, rue Jean-Burguet, 33075 Bordeaux, France. · Clinique de dermatologie, d'allergologie et de photobiologie, centre hospitalier Albert-Michallon, boulevard de la Chantourne, BP 217, 38043 Grenoble cedex 9, France; Inserm U832, institut A.-Bonniot, 38043 Grenoble cedex 09, France. · Pubmed 25656856
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Mater Hospital, Sydney, NSW, Australia. Electronic address: · Moscow City Oncology Hospital, Moscow, Russia. · Department of Medicine, University of Athens, Medical School, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Royal Marsden Hospital, London, UK. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, Hôpital Saint André, CHU Bordeaux, Bordeaux, France. · University Hospital Schleswig-Holstein, Kiel, Germany. · Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padua, Italy. · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Paris, France. · Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA, Australia. · Department of Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. · University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; German Cancer Research Center, Heidelberg, Germany. · Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Volograd Regional Oncology Dispensary #3, Volzhsky, Russia. · Elbe Klinikum Stade, Stade, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · University Hospital Essen, Essen, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Villejuif-Paris-Sud, France; Paris Sud University, Le Kremlin Bicêtre, France. · David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Merck & Co, Kenilworth, NJ, USA. · Massachusetts General Hospital Cancer Center, Boston MA, USA. · Pubmed 26037941
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Universitätsklinikum Essen, Hufelandstr. 55, Essen 45147, Germany. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Moscow City Oncology Hospital #62, Moscow 143423, Russia. Electronic address: · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. Electronic address: · University of Athens, Aghiou Thoma 17, Athens 11527, Greece. Electronic address: · Fondazione IRCCS Istituto Nazionale Tumori, via Giacomo Venezian, 1, Milan, Italy. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Sainte-Marguerite, 270 Boulevard de Sainte-Marguerite, Marseille 13009, France. Electronic address: · Dnepropetrovsk State Medical Academy, Dzerzhyns'koho Street 9, Dnepropetrovsk 49044, Ukraine. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Liebermeisterstraße 25, Tuebingen 72076, Germany. Electronic address: · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, via Gattamelata, 64, Padua 35128, Italy. Electronic address: · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA 6009, Australia. Electronic address: · Hospital Clinic, Carrer Villarroel 170, Barcelona 08036, Spain. Electronic address: · Papa Giovanni XIII Hospital, Piazza OMS 1, Bergamo 24127, Italy. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston 02114, MA, United States. Electronic address: · Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN, United Kingdom. Electronic address: · David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles 90095, CA, United States. Electronic address: · Gustave Roussy and Paris 11 University, 114 Rue Edouard Vaillant, Villejuif-Paris-Sud 94805, France. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Melanoma Institute Australia & The University of Sydney, 40 Rocklands Road, Sydney 2060, Australia. Electronic address: · Pubmed 25794603
  • INSERM UMR-S 976, Paris, France. · Département de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, France. · Laboratoire de Pharmacologie Biologique, AP-HP, Hôpital Saint-Louis, Paris, France. · Neurobiologie intégrative des systémes cholinergiques CNRS UMR 3571-Département de Neuroscience- Institut Pasteur-25, rue du Dr Roux- 75724, Paris, Cedex 15, France. · Université Paris Est Créteil, CNRS-UMR 7149, Créteil, France. · Pubmed 25807898
  • APHP Department of Dermatology Hôpital Saint-Louis, 1, avenue Claude-Vellefaux. 75010 Paris, France; Université Paris 7-Diderot, INSERM U976. · APHP Department of Biostatistics and Medical Information, Hôpital Saint-Louis; ECSTRA Team, CRESS UMR 1153, INSERM, Paris Diderot University. · APHP Department of Pharmacy Hôpital Saint-Louis ; Université Paris 7-Diderot, Paris, France. · Pubmed 25500362
2014
  • Département de médecine, Institut Gustave Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Comité de rédaction du Bulletin du Cancer. · Service de dermatologie, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Comité de rédaction du Bulletin du Cancer; Service oncologie hématologie, Hôpital Louis-Pasteur, 4, rue Claude-Bernard, 28630 Le Coudray, France. · Pubmed 25776765
  • AP-HP, Hôpital Saint-Louis, Laboratoire de pharmacologie-génétique, 1, avenue Claude-Vellefaux, 75010 Paris, France; Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Centre d'oncodermatologie, AP-HP, Hôpital Saint-Louis, Département de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776766
  • Hôpital Saint-Louis, Service de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Hôpital Saint-Louis, Service de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776764
  • Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, 375 Longwood Ave, Mailstop: MASCO 428, Boston, MA 02215, USA. Electronic address: · APHP Department of Dermatology, CIC, U976 Hôpital Saint-Louis University Paris Diderot, 1 Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Center for Immuno-Oncology, Melanoma Center, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena 53100, Italy. Electronic address: · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. Electronic address: · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: · Seattle Cancer Care Alliance, 825 Eastlake Ave E, G4-830, Seattle, WA 98109, USA. Electronic address: · Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: · Pubmed 25060490
  • Department of Dermatology, APHP, CIC, U976 Hôpital Saint-Louis University Paris Diderot, Paris, France · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Melanoma Therapeutics, Translational Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles. · Los Angeles Skin Cancer Institute at Beverly Hills Cancer Center, Beverly Hills. · Global Clinical Research. · Global Biometric Sciences, Bristol-Myers Squibb Company, Wallingford. · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 25210016
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Université Paris Est Créteil, CNRS-UMR; Créteil, France. · Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Inserm UMR-S 940 Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Service d'oncologie médicale, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Hematology Laboratory APHP, Saint-Louis Hospital, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, Paris, France. Inserm U 975, Paris, 75013 France, CNRS, UMR, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Inserm, U728, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pathologie, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France. Inserm U976, Paris, France. · Pubmed 25344860
  • aAP-HP, Department of Dermatology, Saint-Louis Hospital bParis-Diderot University, Sorbonne Paris Cite cINSERM U976 dLaboratory for Functional Genomics, Jean Dausset Fondation - CEPH eAP-HP, Pathology Laboratory, Saint-Louis Hospital, INSERM UMR_S 1165 fAP-HP, Saint-Louis Hospital, Pharmacology-Genetic Laboratory gDepartment of Biostatistics and Medical Data Processing, INSERM-U717 hLaboratory for Epigenetics and Environment, Genotyping National Center, CEA, Genomic Institute iINSERM UMR-S 940, Paris, France. · Pubmed 24933605
  • Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Pharmacology-Genetics Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Dermatology Department, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 976, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Jean Dausset Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. Electronic address: · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. Electronic address: · Pubmed 24499734
2012
  • Department of Dermatology, APHP U976, Paris 7 Diderot University, Hôpital Saint-Louis, Paris, France. · Pubmed 22742880
  • Département de Dermatologie, hôpital saint Louis Paris, Paris, France. · Pubmed 22272228
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan; Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Celeste Lebbé, Université Paris Diderot, Paris; Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA; Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel; Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA; Jessica Hassel, University Hospital, Heidelberg, Germany; Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria; Winald Gerritsen, University of Queensland, St Lucia; Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes; Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands; John McCaffrey, Irish Clinical Oncology Research Group, Dublin; Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland; Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
  • aAPHP, Dermatology Department bAPHP, Pharmacology Department cAPHP, Pharmacogenomic Laboratory dAPHP, Pathology Department eAPHP, Nuclear Medicine Department, Saint-Louis Hospital fAPHP, Neuropathology Laboratory gAPHP, Reference Center of Neuro-muscular Disease, Pitié Salpétrière Hospital hUniversité Paris VI Pierre et Marie Curie, Paris iINSERM U976 jINSERM U1165 kUniversité Paris Diderot-Paris VII, Sorbonne Paris Cité, France. · Pubmed 28692456
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
  • aDepartment of Dermatology, Saint-Louis Hospital bMelBase, Assistance publique hôpitaux de Paris cCRESS UMR 1153, Centre de recherche épidémiologie et statistique Sorbonne Paris cité, Paris, France. · Pubmed 27926587
  • From Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard Hospital, Saint-Louis Hospital, and Saint-Antoine Hospital; Université Paris Diderot; Sorbonne Paris Cité; and Institut National de la Santé et de la Recherche Médicale, Paris, France. · Pubmed 28869988
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Departments of aDermatology bGastroenterology cPathology, Saint-Louis Hospital, Paris, France. · Pubmed 26990271
  • Affiliations of authors: INSERM, U976, Centre de Recherche sur la Peau, Hôpital Saint Louis , Paris , France (HHH, JA, SM, LM, VD, NBS, MB, AB, CL, ND, NS); AP-HP, Hôpital Bichat Claude Bernard, Département de Génétique , Paris , France (HHH, CK, AT, BG, NS); Université Paris Diderot, Sorbonne Paris Cité , UMRS976, Paris , France (HHH, CK, JA, LM, NBS, MB, AB, LD, AT, BG, ND, NS); Université Paris 6, INSERM UMRS975, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, AP-HP , Paris , France (SL, AB); INSERM, U940, Laboratoire de Pharmacologie, Hôpital Saint Louis Paris , France (SM); AP-HP, Hôpital Bichat Claude Bernard, Service de Dermatologie , Paris , France (VD); AP-HP, Hôpital Saint Louis, Service de Dermatologie , Paris , France (NBS, MB, CL, ND); INSERM, CRB3, Département de Pathologie, Hôpital Bichat, AP-HP , Paris , France (LD); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie , Boulogne Billancourt , France (PS); CHU Grenoble, Service de Dermatologie , Grenoble , France (MTL); Gustave Roussy, Service de Génétique, Département de Biopathologie , Villejuif , France (BBdP); Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580 , Heidelberg , Germany (RK); Department of Neurology, University Hospital of Würzburg , Würzburg , Germany (SK); Inserm UMR1037, Centre de Recherche en Cancérologie de Toulouse , Toulouse , France (NAA); Hôpital de l'Hôtel-Dieu, Service de Dermatologie , Lyon , France (LT); AP-HP, Groupe Pitié-Salpêtrière, Département de Génétique, Cytogénétique et Embryologie , Paris , France (AB). · Pubmed 26683220
2015
  • aDepartment of Dermatology, University Hospital Zürich, Zürich, Switzerland bDepartment of Dermatology, University Hospital Essen, Essen cDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany dIstituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy eRoyal Marsden NHS Foundation Trust, London, UK fAPHP Oncodermatology Unit, University Paris 7 Diderot U976, Paris, France. · Pubmed 26426764
  • Departments of aDermatology bPathology cPharmacology, Hôpital Saint Louis, APHP dINSERM U976, Université Paris 7 Diderot, Paris, France. · Pubmed 26397052
  • Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Pubmed 26376687
  • aAP-HP, Oncodermatology Unit, Dermatology Department bAP-HP, Pathology Department cAP-HP, Radiology Department dAP-HP, Pharmacology-Genetic Laboratory eAP-HP, Department of Biostatistics and Medical Data Processing, Saint-Louis Hospital, Paris 7 Diderot University fParis Diderot University, Sorbonne Paris Cité, UMR-S 728 gParis Diderot University, Sorbonne Paris Cité, UMR 976 hINSERM, U728 iINSERM, U976, Paris, France. · Pubmed 25933210
  • aAPHP service de dermatologie bAPHP centre d'investigation clinique cAPHP Service de gastro-entérologie, hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris dUniversité Paris Diderot Paris 7, INSERM U976. · Pubmed 25464388
  • aINSERM, U976, Skin Research Institute, Hôpital Saint Louis bUniversité Paris Diderot, Sorbonne Paris Cité cDermatology Department dPharmacology Department, AP-HP, Hôpital Saint Louis, Paris, France. · Pubmed 25304235
2014
  • aDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas bDivision of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA cDermatology Polyclinic, Saint Louis Hospital, Paris dDepartment of Dermatology, Aix-Marseille University, Marseille, France eDepartment of Dermatology, University Medical Centre, Tubingen, Germany. · Pubmed 24667300
  • Departments of aDermatology bHemato-oncology cAnatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France. · Pubmed 24743053
  • Departments of aDermatology bPharmacy cPathology dPharmacology Laboratory, Saint Louis Hospital eDepartment of Biostatistics, Hotel Dieu Hospital fINSERM U976 gParis 7 Diderot University, Paris, France. · Pubmed 24241686
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Department of Dermatology, Saint-Louis Hospital, 75475 Paris Cedex 10, France. · Pubmed 23458760
2012
  • Dermatology Department, Université Paris VII-Saint-Louis Hospital, Paris, France. · Pubmed 21615526
2010
  • Department of Dermatology, Hôpital Saint Louis Assistance Publique-Hôpitaux Paris, University of Paris 7, INSERM U976, Paris, France. · Pubmed 20216240
2009
  • Centre d'Investigations Cliniques, Hôpital Saint Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France. · Pubmed 19858763
2008
  • Services de médecine nucléaire, hôpital Saint-louis, AP-HP, université Paris-7, 1 avenue Claude-Vellefaux, Paris cedex 10, France. · Pubmed 18929924
  • Nuclear Medicine Department, Saint-Louis Hospital AP-HP, Paris 7 University, Paris, France. · Pubmed 18771348
Probable:    INSERM Paris      
2017
  • Université Paris-Diderot, Sorbonne-Paris-Cité, APHP services de dermatologie et CIC, hôpital Saint-Louis-Paris, INSERM U976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Département de médecine, service de dermatologie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris-Sud, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28063593
  • AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Diabetology Department, Lariboisière Hospital, Paris, France. · INSERM U1138, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Pharmacology Department, Saint-Louis Hospital, Paris, France. · AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, Paris, France. · AP-HP Hormonology Department, Saint-Louis Hospital, Paris, France. · Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · Pubmed 28634815
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. Electronic address: · Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pharmacy, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Nuclear Medecine Unit, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Rheumatology Department, INSERM UMR 1132, Lariboisière Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pubmed 28438383
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2016
  • Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK. Electronic address: · Servicio de Dermatología, Hospital Clínic de Barcelona, Catalonia, Spain. · Assistance Publique - Hôpitaux de Paris (AP-HP) Hôpital Saint-Louis, Dermatology Department Université Paris-Diderot, Sorbonne Paris Cité, INSERM UMR-S 976, Paris, France. · Adelphi Values, Bollington, UK. · Amgen Ltd., Uxbridge, London UK. · Amgen GmbH, Zug, Switzerland. · Klinik für Dermatologie, Universitätsklinikum Essen, Essen, Germany. · Pubmed 27118416
  • INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France; Inserm UMRS-1131, Institut Universitaire d'Hématologie, Paris, France. · Centre d'Epidémiologie Clinique, Hôtel-Dieu, AP-HP, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; INSERM, UMR 1153, Centre de Recherche Epidémiologie et Statistique (CRESS), Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France. · Service de Dermatologie, Hôpital Xavier Bichat, AP-HP, Paris, France. · Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France; INSERM UMR-976, Hôpital Saint-Louis, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 27728898
  • Kantar Health, Paris, France. · Amgen, Centre for Observational Research, Uxbridge, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. · APHP Dermatology and CIC Hospital Saint Louis University Paris 7, INSERM U976, Paris, France. · Department of Dermatology, University Hospital Duisburg-Essen, Essen, Germany. · Pubmed 27628317
  • Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Dermatology Unit, Hospices Civils de Lyon CH Lyon Sud, Pierre Bénite Cedex, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Department of Biopathology, Centre Léon Bérard, Lyon, France. · Department of Biopathology, Hospices Civils de Lyon CH Lyon Sud, Pierre-Bénite Cedex, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · INSERM U1065 Equipe 1 Biologie et pathologies des mélanocytes: de la pigmentation cutanée au mélanome Equipe labellisée Ligue 2013 Centre Méditerranéen de Médecine Moléculaire, Nice, France Université de Nice Sophia-Antipolis UFR Médecine, Nice, France CHU Nice Service de Dermatologie, Nice, France. · APHP INSERM U976 Saint Louis Hospital Pharmacology-Genetic Laboratory Paris, Paris, France. · Department of Pathology, INSERM U1165 Université Paris Diderot AP-HP Hôpital Saint-Louis, Paris, France. · Department of Dermatology, APHP Saint Louis Hospital, Paris, France INSERM U976 University Paris 7 Diderot, Paris, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Institut Universitaire de France, Paris, France · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France · Pubmed 27596438
  • Inserm U 976, Paris, France. · Inserm U 1165, Paris, France. · Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Department of Pathology, AP-HP, Hôpital Saint-Louis, Paris, France. · INSERM, IAME, UMR 1137, Paris, France. · Department of Biochemistry, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of plastic surgery, AP-HP, Hôpital Saint-Louis, Paris, France. · EA4340, Versailles University, Boulogne-Billancourt, France. · AP-HP, Ambroise Paré Hospital, Department of Dermatology, Boulogne-Billancourt, France. · AP-HP, Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, Paris, France. · Laboratoire CRRET, CNRS-UMR 7149, Créteil, France. · Université Paris 12, Créteil, France. · Pubmed 27060463
  • Dermatology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Nephrology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Physiology Department, DHU Fire, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Biostatistic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, ECSTRA Team, Inserm UMR-1153, Université Paris 7 Diderot, Paris, France. · Biochemistry Department, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Pharmacology and Genetic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Inserm Unit 976, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 26930506
  • INSERM UMR_S976, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Dermatology, Paris, F-75010, France. · Université Paris-Diderot, Sorbonne Paris Cité, Paris, F-75013, France. · INSERM UMR_S1165, Paris, F-75010, France. · Université Paris-Diderot, Department of Pathology, UMR_S1165, Paris, F-75010, France. · UMR CNRS 8612, Institut Galien-UFR de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, F-92290, France. · INSERM UMR_1137, Paris, F-75018, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie Biologique, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Plastic, Reconstructive and Esthetic Surgery, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Pathology, Paris, F-75010, France. · Pubmed 26909610
  • Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris · Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris. · INSERM, IAME, UMR 1137, Université Paris Diderot, Paris. · Deparment of Pharmacy, AP-HP, Saint-Louis Hospital, Paris, France. · Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris. · Pubmed 26578723
2015
  • AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 25965357
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Mater Hospital, Sydney, NSW, Australia. Electronic address: · Moscow City Oncology Hospital, Moscow, Russia. · Department of Medicine, University of Athens, Medical School, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Royal Marsden Hospital, London, UK. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, Hôpital Saint André, CHU Bordeaux, Bordeaux, France. · University Hospital Schleswig-Holstein, Kiel, Germany. · Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padua, Italy. · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Paris, France. · Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA, Australia. · Department of Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. · University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; German Cancer Research Center, Heidelberg, Germany. · Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Volograd Regional Oncology Dispensary #3, Volzhsky, Russia. · Elbe Klinikum Stade, Stade, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · University Hospital Essen, Essen, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Villejuif-Paris-Sud, France; Paris Sud University, Le Kremlin Bicêtre, France. · David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Merck & Co, Kenilworth, NJ, USA. · Massachusetts General Hospital Cancer Center, Boston MA, USA. · Pubmed 26037941
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Universitätsklinikum Essen, Hufelandstr. 55, Essen 45147, Germany. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Moscow City Oncology Hospital #62, Moscow 143423, Russia. Electronic address: · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. Electronic address: · University of Athens, Aghiou Thoma 17, Athens 11527, Greece. Electronic address: · Fondazione IRCCS Istituto Nazionale Tumori, via Giacomo Venezian, 1, Milan, Italy. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Sainte-Marguerite, 270 Boulevard de Sainte-Marguerite, Marseille 13009, France. Electronic address: · Dnepropetrovsk State Medical Academy, Dzerzhyns'koho Street 9, Dnepropetrovsk 49044, Ukraine. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Liebermeisterstraße 25, Tuebingen 72076, Germany. Electronic address: · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, via Gattamelata, 64, Padua 35128, Italy. Electronic address: · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA 6009, Australia. Electronic address: · Hospital Clinic, Carrer Villarroel 170, Barcelona 08036, Spain. Electronic address: · Papa Giovanni XIII Hospital, Piazza OMS 1, Bergamo 24127, Italy. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston 02114, MA, United States. Electronic address: · Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN, United Kingdom. Electronic address: · David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles 90095, CA, United States. Electronic address: · Gustave Roussy and Paris 11 University, 114 Rue Edouard Vaillant, Villejuif-Paris-Sud 94805, France. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Melanoma Institute Australia & The University of Sydney, 40 Rocklands Road, Sydney 2060, Australia. Electronic address: · Pubmed 25794603
  • INSERM UMR-S 976, Paris, France. · Département de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, France. · Laboratoire de Pharmacologie Biologique, AP-HP, Hôpital Saint-Louis, Paris, France. · Neurobiologie intégrative des systémes cholinergiques CNRS UMR 3571-Département de Neuroscience- Institut Pasteur-25, rue du Dr Roux- 75724, Paris, Cedex 15, France. · Université Paris Est Créteil, CNRS-UMR 7149, Créteil, France. · Pubmed 25807898
  • APHP Department of Dermatology Hôpital Saint-Louis, 1, avenue Claude-Vellefaux. 75010 Paris, France; Université Paris 7-Diderot, INSERM U976. · APHP Department of Biostatistics and Medical Information, Hôpital Saint-Louis; ECSTRA Team, CRESS UMR 1153, INSERM, Paris Diderot University. · APHP Department of Pharmacy Hôpital Saint-Louis ; Université Paris 7-Diderot, Paris, France. · Pubmed 25500362
2014
  • AP-HP, Hôpital Saint-Louis, Laboratoire de pharmacologie-génétique, 1, avenue Claude-Vellefaux, 75010 Paris, France; Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Centre d'oncodermatologie, AP-HP, Hôpital Saint-Louis, Département de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776766
  • Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Université Paris Est Créteil, CNRS-UMR; Créteil, France. · Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Inserm UMR-S 940 Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Service d'oncologie médicale, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Hematology Laboratory APHP, Saint-Louis Hospital, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, Paris, France. Inserm U 975, Paris, 75013 France, CNRS, UMR, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Inserm, U728, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pathologie, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France. Inserm U976, Paris, France. · Pubmed 25344860
  • aAP-HP, Department of Dermatology, Saint-Louis Hospital bParis-Diderot University, Sorbonne Paris Cite cINSERM U976 dLaboratory for Functional Genomics, Jean Dausset Fondation - CEPH eAP-HP, Pathology Laboratory, Saint-Louis Hospital, INSERM UMR_S 1165 fAP-HP, Saint-Louis Hospital, Pharmacology-Genetic Laboratory gDepartment of Biostatistics and Medical Data Processing, INSERM-U717 hLaboratory for Epigenetics and Environment, Genotyping National Center, CEA, Genomic Institute iINSERM UMR-S 940, Paris, France. · Pubmed 24933605
  • Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Pharmacology-Genetics Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Dermatology Department, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 976, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Jean Dausset Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. Electronic address: · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. Electronic address: · Pubmed 24499734
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Affiliations of authors: INSERM, U976, Centre de Recherche sur la Peau, Hôpital Saint Louis , Paris , France (HHH, JA, SM, LM, VD, NBS, MB, AB, CL, ND, NS); AP-HP, Hôpital Bichat Claude Bernard, Département de Génétique , Paris , France (HHH, CK, AT, BG, NS); Université Paris Diderot, Sorbonne Paris Cité , UMRS976, Paris , France (HHH, CK, JA, LM, NBS, MB, AB, LD, AT, BG, ND, NS); Université Paris 6, INSERM UMRS975, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, AP-HP , Paris , France (SL, AB); INSERM, U940, Laboratoire de Pharmacologie, Hôpital Saint Louis Paris , France (SM); AP-HP, Hôpital Bichat Claude Bernard, Service de Dermatologie , Paris , France (VD); AP-HP, Hôpital Saint Louis, Service de Dermatologie , Paris , France (NBS, MB, CL, ND); INSERM, CRB3, Département de Pathologie, Hôpital Bichat, AP-HP , Paris , France (LD); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie , Boulogne Billancourt , France (PS); CHU Grenoble, Service de Dermatologie , Grenoble , France (MTL); Gustave Roussy, Service de Génétique, Département de Biopathologie , Villejuif , France (BBdP); Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580 , Heidelberg , Germany (RK); Department of Neurology, University Hospital of Würzburg , Würzburg , Germany (SK); Inserm UMR1037, Centre de Recherche en Cancérologie de Toulouse , Toulouse , France (NAA); Hôpital de l'Hôtel-Dieu, Service de Dermatologie , Lyon , France (LT); AP-HP, Groupe Pitié-Salpêtrière, Département de Génétique, Cytogénétique et Embryologie , Paris , France (AB). · Pubmed 26683220
2015
  • Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Pubmed 26376687
  • aAPHP service de dermatologie bAPHP centre d'investigation clinique cAPHP Service de gastro-entérologie, hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris dUniversité Paris Diderot Paris 7, INSERM U976. · Pubmed 25464388
2010
  • Inserm, UMR-S 940 Laboratoire de Pharmacologie, Paris, France. · Pubmed 20824203
  • Department of Dermatology, Hôpital Saint Louis Assistance Publique-Hôpitaux Paris, University of Paris 7, INSERM U976, Paris, France. · Pubmed 20216240
Probable:    Miscellaneous institutions in Paris      
2017
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2014
  • Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, 75010, Paris, France. · Pubmed 24969466
2012
  • Department of Dermatology, St-Louis Hospital, Paris, France. · Pubmed 22828248
2009
  • Unité Fonctionnelle Diagnostic Biologique Automatise, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7151, Paris, France. · Pubmed 19841396
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 101 total) written by Celeste Lebbe about Melanoma:

  • [Treating metastatic melanoma: Risk management]. 2017
  • Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review. 2017
  • Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma. 2017
  • Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. 2017
  • Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. 2017
  • Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. 2017
  • Dabrafenib plus trametinib in patients with BRAF 2017
  • Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. 2017
  • Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. 2017
  • Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Celeste Lebbe using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite Paris 7 Diderot
INSERM Paris
Miscellaneous institutions in Paris
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite Paris 7 Diderot
2017
  • Université Paris-Diderot, Sorbonne-Paris-Cité, APHP services de dermatologie et CIC, hôpital Saint-Louis-Paris, INSERM U976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Département de médecine, service de dermatologie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris-Sud, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28063593
  • AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Diabetology Department, Lariboisière Hospital, Paris, France. · INSERM U1138, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Pharmacology Department, Saint-Louis Hospital, Paris, France. · AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, Paris, France. · AP-HP Hormonology Department, Saint-Louis Hospital, Paris, France. · Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · Pubmed 28634815
  • Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, T2-041, Toronto, ON, M4N 3M5, Canada. Electronic address: · Gustave Roussy and Université Paris-Sud, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Medical University of Graz, Auenbruggerpl. 2, 8036 Graz, Graz, Austria. Electronic address: · Segal Cancer Centre, Jewish General Hospital, Rossy Cancer Network, and McGill University, 3755 Ch de la Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, Canada. Electronic address: · Karolinska Institute, Solnavägen 1, 171 77 Solna, Stockholm, Sweden. Electronic address: · Princess Alexandra Hospital and The University of Queensland, 199 Ipswich Rd, Woolloongabba, Brisbane, QLD 4102, Australia. Electronic address: · APHP, Dermatology and CIC, Université Paris Diderot, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France. Electronic address: · Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham B15 2TH, UK. Electronic address: · The Churchill Hospital and The University of Oxford, Old Rd, Headington, Oxford OX3 7LE, UK. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, La Trobe University, 145 Studley Road, Heidelberg VIC 3084, Melbourne, Australia. Electronic address: · Pubmed 28987768
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. Electronic address: · Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pharmacy, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Nuclear Medecine Unit, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Rheumatology Department, INSERM UMR 1132, Lariboisière Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pubmed 28438383
  • Department of Dermatology, Medical Faculty, Military Medical Academy, Belgrade, Serbia. · Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. · National and Kapodistrian University of Athens, Greece. · Service de Dermatologie et Cancérologie Cutanée, Hopital de la Timone, Marseille, France. · Mount Vernon Cancer Centre, Northwood, United Kingdom. · UniversitätsSpital Zürich-Skin Cancer Center, University Hospital, Zürich, Switzerland. · Carol Davila University of Medicine and Pharmacy, Elias University Hospital Bucharest, Romania. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · NN Blokhin Russian Cancer Research Center, Moscow, Russia. · APHP Hospital Saint Louis, Paris, France. · Netherland Cancer Institute, Amsterdam, Netherlands. · Department of Dermatology and Allergology, University of Szeged, Hungary. · Department of Oncology, Odense University Hospital, Denmark. · Department of Oncology, University Hospital Zagreb, Croatia. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium. · Department of Dermatology, Medical Faculty, University of Coimbra, Portugal. · Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden. · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland. · General Teaching Hospital, Prague, Czech Republic. · Department of Dermatology, Vilnius University, Lithuania. · Division of Dermatology and Venerology, Medical University of Graz, Graz, Austria. · University Hospital Center Sestre Milosrdnice, Zagreb, Croatia. · Institute of Oncology and Radiology of Serbia, Belgrade, Serbia. · Department of Oncology, University Hospital Sarajevo, Bosnia and Herzegovina. · North Estonia Medical Centre, Tallinn, Estonia. · Department of Dermatology & Venerology & Allergy, Medical University Innsbruck, Austria. · Clinic for Oncology and Radiotherapy, Podgorica, Montenegro. · Clinic of Oncodermatology, National Cancer Center, Sofia, Bulgaria. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · N.N. Alexandrov National Cancer Сenter of Belarus (NCCB), Minsk, Belarus. · National Cancer Institute, Kiev, Ukraine. · Department of Clinical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain. · University Hospital Mother Theresa, Tirana, Albania. · University Clinic of Radiotherapy and Oncology, Skopje, Former Yugoslav Republic of Macedonia. · Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · Pubmed 28264791
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2016
  • Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK. Electronic address: · Servicio de Dermatología, Hospital Clínic de Barcelona, Catalonia, Spain. · Assistance Publique - Hôpitaux de Paris (AP-HP) Hôpital Saint-Louis, Dermatology Department Université Paris-Diderot, Sorbonne Paris Cité, INSERM UMR-S 976, Paris, France. · Adelphi Values, Bollington, UK. · Amgen Ltd., Uxbridge, London UK. · Amgen GmbH, Zug, Switzerland. · Klinik für Dermatologie, Universitätsklinikum Essen, Essen, Germany. · Pubmed 27118416
  • Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France. Electronic address: · Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France. · Pubmed 26944639
  • Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud 75005, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Versailles 78000, France. · CHU de Nantes-Hôtel Dieu, Nantes 44093, France. · Radiotherapy Department, Institut Curie, Paris 75005, France. · La Timone Hospital-APHM, Aix-Marseille University, Marseille 13385, France. · Dermatology department, Saint-André Hospital, CHU de Bordeaux, Bordeaux 33000, France. · Lyon Sud Hospital Center, Lyon 1 University, Pierre Benite 69495, France. · Saint-Louis Hospital, APHP, Paris 75010, France. · Dermatology department, CHRU of Lille, Lille 59037, France. · Ambroise Paré Hospital, Boulogne Billancourt 92104, France. · Cochin hospital, APHP, Paris 75014, France. · Bichat Hospital, Paris 75877, France. · CHU Rouen, Charles-Nicolle, Rouen 76000, France. · Institut Curie, Paris 75005, France. · DNA Therapeutics, Evry 91058, France. · Department of Biostatistics, Institut Curie, Paris 75005, France. · Institut Curie, Orsay 91405, France. · CNRS-UMR3347, INSERM-U1021, Paris-Sud University, Orsay 91405, France. · Pubmed 27140316
  • INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France; Inserm UMRS-1131, Institut Universitaire d'Hématologie, Paris, France. · Centre d'Epidémiologie Clinique, Hôtel-Dieu, AP-HP, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; INSERM, UMR 1153, Centre de Recherche Epidémiologie et Statistique (CRESS), Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France. · Service de Dermatologie, Hôpital Xavier Bichat, AP-HP, Paris, France. · Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France; INSERM UMR-976, Hôpital Saint-Louis, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 27728898
  • Kantar Health, Paris, France. · Amgen, Centre for Observational Research, Uxbridge, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. · APHP Dermatology and CIC Hospital Saint Louis University Paris 7, INSERM U976, Paris, France. · Department of Dermatology, University Hospital Duisburg-Essen, Essen, Germany. · Pubmed 27628317
  • Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Dermatology Unit, Hospices Civils de Lyon CH Lyon Sud, Pierre Bénite Cedex, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Department of Biopathology, Centre Léon Bérard, Lyon, France. · Department of Biopathology, Hospices Civils de Lyon CH Lyon Sud, Pierre-Bénite Cedex, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · INSERM U1065 Equipe 1 Biologie et pathologies des mélanocytes: de la pigmentation cutanée au mélanome Equipe labellisée Ligue 2013 Centre Méditerranéen de Médecine Moléculaire, Nice, France Université de Nice Sophia-Antipolis UFR Médecine, Nice, France CHU Nice Service de Dermatologie, Nice, France. · APHP INSERM U976 Saint Louis Hospital Pharmacology-Genetic Laboratory Paris, Paris, France. · Department of Pathology, INSERM U1165 Université Paris Diderot AP-HP Hôpital Saint-Louis, Paris, France. · Department of Dermatology, APHP Saint Louis Hospital, Paris, France INSERM U976 University Paris 7 Diderot, Paris, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Institut Universitaire de France, Paris, France · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France · Pubmed 27596438
  • Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. Electronic address: · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Clinical Investigation Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Nuclear Medicine Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Pathology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Plastic Surgery Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France. · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Onco-Dermatology, Immunology and Cutaneous Stem Cells, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pneumology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Biostatistics and Clinical Epidemiology research team, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Clinical Investigation Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Onco-Dermatology, Immunology and Cutaneous Stem Cells, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 27157227
  • Inserm U 976, Paris, France. · Inserm U 1165, Paris, France. · Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Department of Pathology, AP-HP, Hôpital Saint-Louis, Paris, France. · INSERM, IAME, UMR 1137, Paris, France. · Department of Biochemistry, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of plastic surgery, AP-HP, Hôpital Saint-Louis, Paris, France. · EA4340, Versailles University, Boulogne-Billancourt, France. · AP-HP, Ambroise Paré Hospital, Department of Dermatology, Boulogne-Billancourt, France. · AP-HP, Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, Paris, France. · Laboratoire CRRET, CNRS-UMR 7149, Créteil, France. · Université Paris 12, Créteil, France. · Pubmed 27060463
  • Dermatology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Nephrology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Physiology Department, DHU Fire, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Biostatistic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, ECSTRA Team, Inserm UMR-1153, Université Paris 7 Diderot, Paris, France. · Biochemistry Department, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Pharmacology and Genetic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Inserm Unit 976, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 26930506
  • INSERM UMR_S976, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Dermatology, Paris, F-75010, France. · Université Paris-Diderot, Sorbonne Paris Cité, Paris, F-75013, France. · INSERM UMR_S1165, Paris, F-75010, France. · Université Paris-Diderot, Department of Pathology, UMR_S1165, Paris, F-75010, France. · UMR CNRS 8612, Institut Galien-UFR de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, F-92290, France. · INSERM UMR_1137, Paris, F-75018, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie Biologique, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Plastic, Reconstructive and Esthetic Surgery, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Pathology, Paris, F-75010, France. · Pubmed 26909610
  • Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris · Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris. · INSERM, IAME, UMR 1137, Université Paris Diderot, Paris. · Deparment of Pharmacy, AP-HP, Saint-Louis Hospital, Paris, France. · Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris. · Pubmed 26578723
2015
  • AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 25965357
  • Neuro-oncologie, département de neurochirurgie, hôpital Roger-Salengro, CHRU, rue Émile-Laine, 59037 Lille cedex, France; Oncologie médicale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France; Inserm U1192, laboratoire Prism, université Lille 1, bâtiment SN3 1(er) étage, 59655 Villeneuve-d'Ascq cedex, France; Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France. Electronic address: · Département de dermatologie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de dermatologie, centre hospitalier régional et universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département de radiothérapie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France; Réunion de concertation pluridisciplinaire de neuro-oncologie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de dermatologie, centre hospitalier universitaire, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Université Montpellier 1, 5, boulevard Henri-IV, CS 19044, 34967 Montpellier cedex 2, France. · Département de dermatologie, centre hospitalo-universitaire, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France. · Département de dermatologie, hôpital Saint-Louis, Assistance publique-Hôpitaux de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Service de dermatologie, pôle d'oncologie-radiothérapie, de dermatologie et des soins palliatifs, groupe hospitalier Saint-André, centre hospitalier universitaire de Bordeaux, 1, rue Jean-Burguet, 33075 Bordeaux, France. · Clinique de dermatologie, d'allergologie et de photobiologie, centre hospitalier Albert-Michallon, boulevard de la Chantourne, BP 217, 38043 Grenoble cedex 9, France; Inserm U832, institut A.-Bonniot, 38043 Grenoble cedex 09, France. · Pubmed 25656856
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Mater Hospital, Sydney, NSW, Australia. Electronic address: · Moscow City Oncology Hospital, Moscow, Russia. · Department of Medicine, University of Athens, Medical School, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Royal Marsden Hospital, London, UK. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, Hôpital Saint André, CHU Bordeaux, Bordeaux, France. · University Hospital Schleswig-Holstein, Kiel, Germany. · Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padua, Italy. · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Paris, France. · Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA, Australia. · Department of Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. · University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; German Cancer Research Center, Heidelberg, Germany. · Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Volograd Regional Oncology Dispensary #3, Volzhsky, Russia. · Elbe Klinikum Stade, Stade, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · University Hospital Essen, Essen, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Villejuif-Paris-Sud, France; Paris Sud University, Le Kremlin Bicêtre, France. · David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Merck & Co, Kenilworth, NJ, USA. · Massachusetts General Hospital Cancer Center, Boston MA, USA. · Pubmed 26037941
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Universitätsklinikum Essen, Hufelandstr. 55, Essen 45147, Germany. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Moscow City Oncology Hospital #62, Moscow 143423, Russia. Electronic address: · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. Electronic address: · University of Athens, Aghiou Thoma 17, Athens 11527, Greece. Electronic address: · Fondazione IRCCS Istituto Nazionale Tumori, via Giacomo Venezian, 1, Milan, Italy. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Sainte-Marguerite, 270 Boulevard de Sainte-Marguerite, Marseille 13009, France. Electronic address: · Dnepropetrovsk State Medical Academy, Dzerzhyns'koho Street 9, Dnepropetrovsk 49044, Ukraine. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Liebermeisterstraße 25, Tuebingen 72076, Germany. Electronic address: · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, via Gattamelata, 64, Padua 35128, Italy. Electronic address: · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA 6009, Australia. Electronic address: · Hospital Clinic, Carrer Villarroel 170, Barcelona 08036, Spain. Electronic address: · Papa Giovanni XIII Hospital, Piazza OMS 1, Bergamo 24127, Italy. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston 02114, MA, United States. Electronic address: · Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN, United Kingdom. Electronic address: · David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles 90095, CA, United States. Electronic address: · Gustave Roussy and Paris 11 University, 114 Rue Edouard Vaillant, Villejuif-Paris-Sud 94805, France. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Melanoma Institute Australia & The University of Sydney, 40 Rocklands Road, Sydney 2060, Australia. Electronic address: · Pubmed 25794603
  • INSERM UMR-S 976, Paris, France. · Département de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, France. · Laboratoire de Pharmacologie Biologique, AP-HP, Hôpital Saint-Louis, Paris, France. · Neurobiologie intégrative des systémes cholinergiques CNRS UMR 3571-Département de Neuroscience- Institut Pasteur-25, rue du Dr Roux- 75724, Paris, Cedex 15, France. · Université Paris Est Créteil, CNRS-UMR 7149, Créteil, France. · Pubmed 25807898
  • APHP Department of Dermatology Hôpital Saint-Louis, 1, avenue Claude-Vellefaux. 75010 Paris, France; Université Paris 7-Diderot, INSERM U976. · APHP Department of Biostatistics and Medical Information, Hôpital Saint-Louis; ECSTRA Team, CRESS UMR 1153, INSERM, Paris Diderot University. · APHP Department of Pharmacy Hôpital Saint-Louis ; Université Paris 7-Diderot, Paris, France. · Pubmed 25500362
2014
  • Département de médecine, Institut Gustave Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Comité de rédaction du Bulletin du Cancer. · Service de dermatologie, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Comité de rédaction du Bulletin du Cancer; Service oncologie hématologie, Hôpital Louis-Pasteur, 4, rue Claude-Bernard, 28630 Le Coudray, France. · Pubmed 25776765
  • AP-HP, Hôpital Saint-Louis, Laboratoire de pharmacologie-génétique, 1, avenue Claude-Vellefaux, 75010 Paris, France; Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Centre d'oncodermatologie, AP-HP, Hôpital Saint-Louis, Département de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776766
  • Hôpital Saint-Louis, Service de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Hôpital Saint-Louis, Service de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776764
  • Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, 375 Longwood Ave, Mailstop: MASCO 428, Boston, MA 02215, USA. Electronic address: · APHP Department of Dermatology, CIC, U976 Hôpital Saint-Louis University Paris Diderot, 1 Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Center for Immuno-Oncology, Melanoma Center, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena 53100, Italy. Electronic address: · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. Electronic address: · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: · Seattle Cancer Care Alliance, 825 Eastlake Ave E, G4-830, Seattle, WA 98109, USA. Electronic address: · Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: · Pubmed 25060490
  • Department of Dermatology, APHP, CIC, U976 Hôpital Saint-Louis University Paris Diderot, Paris, France · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Melanoma Therapeutics, Translational Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles. · Los Angeles Skin Cancer Institute at Beverly Hills Cancer Center, Beverly Hills. · Global Clinical Research. · Global Biometric Sciences, Bristol-Myers Squibb Company, Wallingford. · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 25210016
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Université Paris Est Créteil, CNRS-UMR; Créteil, France. · Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Inserm UMR-S 940 Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Service d'oncologie médicale, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Hematology Laboratory APHP, Saint-Louis Hospital, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, Paris, France. Inserm U 975, Paris, 75013 France, CNRS, UMR, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Inserm, U728, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pathologie, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France. Inserm U976, Paris, France. · Pubmed 25344860
  • aAP-HP, Department of Dermatology, Saint-Louis Hospital bParis-Diderot University, Sorbonne Paris Cite cINSERM U976 dLaboratory for Functional Genomics, Jean Dausset Fondation - CEPH eAP-HP, Pathology Laboratory, Saint-Louis Hospital, INSERM UMR_S 1165 fAP-HP, Saint-Louis Hospital, Pharmacology-Genetic Laboratory gDepartment of Biostatistics and Medical Data Processing, INSERM-U717 hLaboratory for Epigenetics and Environment, Genotyping National Center, CEA, Genomic Institute iINSERM UMR-S 940, Paris, France. · Pubmed 24933605
  • Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Pharmacology-Genetics Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Dermatology Department, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 976, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Jean Dausset Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. Electronic address: · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. Electronic address: · Pubmed 24499734
2012
  • Department of Dermatology, APHP U976, Paris 7 Diderot University, Hôpital Saint-Louis, Paris, France. · Pubmed 22742880
  • Département de Dermatologie, hôpital saint Louis Paris, Paris, France. · Pubmed 22272228
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan; Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Celeste Lebbé, Université Paris Diderot, Paris; Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA; Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel; Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA; Jessica Hassel, University Hospital, Heidelberg, Germany; Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria; Winald Gerritsen, University of Queensland, St Lucia; Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes; Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands; John McCaffrey, Irish Clinical Oncology Research Group, Dublin; Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland; Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
  • aAPHP, Dermatology Department bAPHP, Pharmacology Department cAPHP, Pharmacogenomic Laboratory dAPHP, Pathology Department eAPHP, Nuclear Medicine Department, Saint-Louis Hospital fAPHP, Neuropathology Laboratory gAPHP, Reference Center of Neuro-muscular Disease, Pitié Salpétrière Hospital hUniversité Paris VI Pierre et Marie Curie, Paris iINSERM U976 jINSERM U1165 kUniversité Paris Diderot-Paris VII, Sorbonne Paris Cité, France. · Pubmed 28692456
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
  • aDepartment of Dermatology, Saint-Louis Hospital bMelBase, Assistance publique hôpitaux de Paris cCRESS UMR 1153, Centre de recherche épidémiologie et statistique Sorbonne Paris cité, Paris, France. · Pubmed 27926587
  • From Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard Hospital, Saint-Louis Hospital, and Saint-Antoine Hospital; Université Paris Diderot; Sorbonne Paris Cité; and Institut National de la Santé et de la Recherche Médicale, Paris, France. · Pubmed 28869988
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Departments of aDermatology bGastroenterology cPathology, Saint-Louis Hospital, Paris, France. · Pubmed 26990271
  • Affiliations of authors: INSERM, U976, Centre de Recherche sur la Peau, Hôpital Saint Louis , Paris , France (HHH, JA, SM, LM, VD, NBS, MB, AB, CL, ND, NS); AP-HP, Hôpital Bichat Claude Bernard, Département de Génétique , Paris , France (HHH, CK, AT, BG, NS); Université Paris Diderot, Sorbonne Paris Cité , UMRS976, Paris , France (HHH, CK, JA, LM, NBS, MB, AB, LD, AT, BG, ND, NS); Université Paris 6, INSERM UMRS975, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, AP-HP , Paris , France (SL, AB); INSERM, U940, Laboratoire de Pharmacologie, Hôpital Saint Louis Paris , France (SM); AP-HP, Hôpital Bichat Claude Bernard, Service de Dermatologie , Paris , France (VD); AP-HP, Hôpital Saint Louis, Service de Dermatologie , Paris , France (NBS, MB, CL, ND); INSERM, CRB3, Département de Pathologie, Hôpital Bichat, AP-HP , Paris , France (LD); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie , Boulogne Billancourt , France (PS); CHU Grenoble, Service de Dermatologie , Grenoble , France (MTL); Gustave Roussy, Service de Génétique, Département de Biopathologie , Villejuif , France (BBdP); Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580 , Heidelberg , Germany (RK); Department of Neurology, University Hospital of Würzburg , Würzburg , Germany (SK); Inserm UMR1037, Centre de Recherche en Cancérologie de Toulouse , Toulouse , France (NAA); Hôpital de l'Hôtel-Dieu, Service de Dermatologie , Lyon , France (LT); AP-HP, Groupe Pitié-Salpêtrière, Département de Génétique, Cytogénétique et Embryologie , Paris , France (AB). · Pubmed 26683220
2015
  • aDepartment of Dermatology, University Hospital Zürich, Zürich, Switzerland bDepartment of Dermatology, University Hospital Essen, Essen cDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany dIstituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy eRoyal Marsden NHS Foundation Trust, London, UK fAPHP Oncodermatology Unit, University Paris 7 Diderot U976, Paris, France. · Pubmed 26426764
  • Departments of aDermatology bPathology cPharmacology, Hôpital Saint Louis, APHP dINSERM U976, Université Paris 7 Diderot, Paris, France. · Pubmed 26397052
  • Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Pubmed 26376687
  • aAP-HP, Oncodermatology Unit, Dermatology Department bAP-HP, Pathology Department cAP-HP, Radiology Department dAP-HP, Pharmacology-Genetic Laboratory eAP-HP, Department of Biostatistics and Medical Data Processing, Saint-Louis Hospital, Paris 7 Diderot University fParis Diderot University, Sorbonne Paris Cité, UMR-S 728 gParis Diderot University, Sorbonne Paris Cité, UMR 976 hINSERM, U728 iINSERM, U976, Paris, France. · Pubmed 25933210
  • aAPHP service de dermatologie bAPHP centre d'investigation clinique cAPHP Service de gastro-entérologie, hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris dUniversité Paris Diderot Paris 7, INSERM U976. · Pubmed 25464388
  • aINSERM, U976, Skin Research Institute, Hôpital Saint Louis bUniversité Paris Diderot, Sorbonne Paris Cité cDermatology Department dPharmacology Department, AP-HP, Hôpital Saint Louis, Paris, France. · Pubmed 25304235
2014
  • aDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas bDivision of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA cDermatology Polyclinic, Saint Louis Hospital, Paris dDepartment of Dermatology, Aix-Marseille University, Marseille, France eDepartment of Dermatology, University Medical Centre, Tubingen, Germany. · Pubmed 24667300
  • Departments of aDermatology bHemato-oncology cAnatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France. · Pubmed 24743053
  • Departments of aDermatology bPharmacy cPathology dPharmacology Laboratory, Saint Louis Hospital eDepartment of Biostatistics, Hotel Dieu Hospital fINSERM U976 gParis 7 Diderot University, Paris, France. · Pubmed 24241686
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Department of Dermatology, Saint-Louis Hospital, 75475 Paris Cedex 10, France. · Pubmed 23458760
2012
  • Dermatology Department, Université Paris VII-Saint-Louis Hospital, Paris, France. · Pubmed 21615526
2010
  • Department of Dermatology, Hôpital Saint Louis Assistance Publique-Hôpitaux Paris, University of Paris 7, INSERM U976, Paris, France. · Pubmed 20216240
2009
  • Centre d'Investigations Cliniques, Hôpital Saint Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France. · Pubmed 19858763
2008
  • Services de médecine nucléaire, hôpital Saint-louis, AP-HP, université Paris-7, 1 avenue Claude-Vellefaux, Paris cedex 10, France. · Pubmed 18929924
  • Nuclear Medicine Department, Saint-Louis Hospital AP-HP, Paris 7 University, Paris, France. · Pubmed 18771348
INSERM Paris
2017
  • Université Paris-Diderot, Sorbonne-Paris-Cité, APHP services de dermatologie et CIC, hôpital Saint-Louis-Paris, INSERM U976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Département de médecine, service de dermatologie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris-Sud, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28063593
  • AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Dermatology Department, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Diabetology Department, Lariboisière Hospital, Paris, France. · INSERM U1138, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · AP-HP Pharmacology Department, Saint-Louis Hospital, Paris, France. · AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, Paris, France. · AP-HP Hormonology Department, Saint-Louis Hospital, Paris, France. · Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France. · Pubmed 28634815
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. Electronic address: · Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pharmacy, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Nuclear Medecine Unit, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Rheumatology Department, INSERM UMR 1132, Lariboisière Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Pubmed 28438383
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2016
  • Guy's & St Thomas' Hospitals NHS Foundation Trust, London, UK. Electronic address: · Servicio de Dermatología, Hospital Clínic de Barcelona, Catalonia, Spain. · Assistance Publique - Hôpitaux de Paris (AP-HP) Hôpital Saint-Louis, Dermatology Department Université Paris-Diderot, Sorbonne Paris Cité, INSERM UMR-S 976, Paris, France. · Adelphi Values, Bollington, UK. · Amgen Ltd., Uxbridge, London UK. · Amgen GmbH, Zug, Switzerland. · Klinik für Dermatologie, Universitätsklinikum Essen, Essen, Germany. · Pubmed 27118416
  • INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France; Inserm UMRS-1131, Institut Universitaire d'Hématologie, Paris, France. · Centre d'Epidémiologie Clinique, Hôtel-Dieu, AP-HP, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; INSERM, UMR 1153, Centre de Recherche Epidémiologie et Statistique (CRESS), Paris, France. · Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France. · Service de Dermatologie, Hôpital Xavier Bichat, AP-HP, Paris, France. · Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France; INSERM UMR-976, Hôpital Saint-Louis, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 27728898
  • Kantar Health, Paris, France. · Amgen, Centre for Observational Research, Uxbridge, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. · APHP Dermatology and CIC Hospital Saint Louis University Paris 7, INSERM U976, Paris, France. · Department of Dermatology, University Hospital Duisburg-Essen, Essen, Germany. · Pubmed 27628317
  • Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Dermatology Unit, Hospices Civils de Lyon CH Lyon Sud, Pierre Bénite Cedex, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Department of Biopathology, Centre Léon Bérard, Lyon, France. · Department of Biopathology, Hospices Civils de Lyon CH Lyon Sud, Pierre-Bénite Cedex, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · INSERM U1065 Equipe 1 Biologie et pathologies des mélanocytes: de la pigmentation cutanée au mélanome Equipe labellisée Ligue 2013 Centre Méditerranéen de Médecine Moléculaire, Nice, France Université de Nice Sophia-Antipolis UFR Médecine, Nice, France CHU Nice Service de Dermatologie, Nice, France. · APHP INSERM U976 Saint Louis Hospital Pharmacology-Genetic Laboratory Paris, Paris, France. · Department of Pathology, INSERM U1165 Université Paris Diderot AP-HP Hôpital Saint-Louis, Paris, France. · Department of Dermatology, APHP Saint Louis Hospital, Paris, France INSERM U976 University Paris 7 Diderot, Paris, France. · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France Institut Universitaire de France, Paris, France · Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France · Pubmed 27596438
  • Inserm U 976, Paris, France. · Inserm U 1165, Paris, France. · Sorbonne Paris Cité, Université Paris Diderot, Paris, France. · Department of Pathology, AP-HP, Hôpital Saint-Louis, Paris, France. · INSERM, IAME, UMR 1137, Paris, France. · Department of Biochemistry, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. · Department of plastic surgery, AP-HP, Hôpital Saint-Louis, Paris, France. · EA4340, Versailles University, Boulogne-Billancourt, France. · AP-HP, Ambroise Paré Hospital, Department of Dermatology, Boulogne-Billancourt, France. · AP-HP, Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, Paris, France. · Laboratoire CRRET, CNRS-UMR 7149, Créteil, France. · Université Paris 12, Créteil, France. · Pubmed 27060463
  • Dermatology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Nephrology Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Physiology Department, DHU Fire, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Biostatistic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, ECSTRA Team, Inserm UMR-1153, Université Paris 7 Diderot, Paris, France. · Biochemistry Department, Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Pharmacology and Genetic Department, Hôpital Saint-Louis, Assistance-Publique-Hôpitaux de Paris, Paris, France. · Inserm Unit 976, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 26930506
  • INSERM UMR_S976, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Dermatology, Paris, F-75010, France. · Université Paris-Diderot, Sorbonne Paris Cité, Paris, F-75013, France. · INSERM UMR_S1165, Paris, F-75010, France. · Université Paris-Diderot, Department of Pathology, UMR_S1165, Paris, F-75010, France. · UMR CNRS 8612, Institut Galien-UFR de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, F-92290, France. · INSERM UMR_1137, Paris, F-75018, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie Biologique, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Plastic, Reconstructive and Esthetic Surgery, Paris, F-75010, France. · AP-HP, Hôpital Saint-Louis, Department of Pathology, Paris, F-75010, France. · Pubmed 26909610
  • Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris · Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris. · INSERM, IAME, UMR 1137, Université Paris Diderot, Paris. · Deparment of Pharmacy, AP-HP, Saint-Louis Hospital, Paris, France. · Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris. · Pubmed 26578723
2015
  • AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France; INSERM U976, Paris 7 University, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: · Pubmed 25965357
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Mater Hospital, Sydney, NSW, Australia. Electronic address: · Moscow City Oncology Hospital, Moscow, Russia. · Department of Medicine, University of Athens, Medical School, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Royal Marsden Hospital, London, UK. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, Hôpital Saint André, CHU Bordeaux, Bordeaux, France. · University Hospital Schleswig-Holstein, Kiel, Germany. · Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padua, Italy. · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Paris, France. · Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA, Australia. · Department of Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. · University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; German Cancer Research Center, Heidelberg, Germany. · Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Volograd Regional Oncology Dispensary #3, Volzhsky, Russia. · Elbe Klinikum Stade, Stade, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · University Hospital Essen, Essen, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Villejuif-Paris-Sud, France; Paris Sud University, Le Kremlin Bicêtre, France. · David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Merck & Co, Kenilworth, NJ, USA. · Massachusetts General Hospital Cancer Center, Boston MA, USA. · Pubmed 26037941
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Universitätsklinikum Essen, Hufelandstr. 55, Essen 45147, Germany. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Moscow City Oncology Hospital #62, Moscow 143423, Russia. Electronic address: · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. Electronic address: · University of Athens, Aghiou Thoma 17, Athens 11527, Greece. Electronic address: · Fondazione IRCCS Istituto Nazionale Tumori, via Giacomo Venezian, 1, Milan, Italy. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Sainte-Marguerite, 270 Boulevard de Sainte-Marguerite, Marseille 13009, France. Electronic address: · Dnepropetrovsk State Medical Academy, Dzerzhyns'koho Street 9, Dnepropetrovsk 49044, Ukraine. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Liebermeisterstraße 25, Tuebingen 72076, Germany. Electronic address: · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, via Gattamelata, 64, Padua 35128, Italy. Electronic address: · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA 6009, Australia. Electronic address: · Hospital Clinic, Carrer Villarroel 170, Barcelona 08036, Spain. Electronic address: · Papa Giovanni XIII Hospital, Piazza OMS 1, Bergamo 24127, Italy. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston 02114, MA, United States. Electronic address: · Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN, United Kingdom. Electronic address: · David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles 90095, CA, United States. Electronic address: · Gustave Roussy and Paris 11 University, 114 Rue Edouard Vaillant, Villejuif-Paris-Sud 94805, France. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Melanoma Institute Australia & The University of Sydney, 40 Rocklands Road, Sydney 2060, Australia. Electronic address: · Pubmed 25794603
  • INSERM UMR-S 976, Paris, France. · Département de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, France. · Laboratoire de Pharmacologie Biologique, AP-HP, Hôpital Saint-Louis, Paris, France. · Neurobiologie intégrative des systémes cholinergiques CNRS UMR 3571-Département de Neuroscience- Institut Pasteur-25, rue du Dr Roux- 75724, Paris, Cedex 15, France. · Université Paris Est Créteil, CNRS-UMR 7149, Créteil, France. · Pubmed 25807898
  • APHP Department of Dermatology Hôpital Saint-Louis, 1, avenue Claude-Vellefaux. 75010 Paris, France; Université Paris 7-Diderot, INSERM U976. · APHP Department of Biostatistics and Medical Information, Hôpital Saint-Louis; ECSTRA Team, CRESS UMR 1153, INSERM, Paris Diderot University. · APHP Department of Pharmacy Hôpital Saint-Louis ; Université Paris 7-Diderot, Paris, France. · Pubmed 25500362
2014
  • AP-HP, Hôpital Saint-Louis, Laboratoire de pharmacologie-génétique, 1, avenue Claude-Vellefaux, 75010 Paris, France; Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: · Inserm, U976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, 1, avenue Claude-Vellefaux, 75010 Paris, France; Centre d'oncodermatologie, AP-HP, Hôpital Saint-Louis, Département de dermatologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Pubmed 25776766
  • Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 940 Paris, France. Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Université Paris Est Créteil, CNRS-UMR; Créteil, France. · Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Inserm UMR-S 940 Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pharmacologie-Génétique, Paris, France. · Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, Paris, France. · AP-HP, Hôpital Saint-Louis, Service d'oncologie médicale, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Hematology Laboratory APHP, Saint-Louis Hospital, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, Paris, France. Inserm U 975, Paris, 75013 France, CNRS, UMR, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Inserm, U728, Paris, France. AP-HP, Hôpital Saint-Louis, Laboratoire de Pathologie, Paris, France. · Institute of Hematology (IUH), Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. AP-HP, Hôpital Saint-Louis, Département de Dermatologie, Paris, France. Inserm U976, Paris, France. · Pubmed 25344860
  • aAP-HP, Department of Dermatology, Saint-Louis Hospital bParis-Diderot University, Sorbonne Paris Cite cINSERM U976 dLaboratory for Functional Genomics, Jean Dausset Fondation - CEPH eAP-HP, Pathology Laboratory, Saint-Louis Hospital, INSERM UMR_S 1165 fAP-HP, Saint-Louis Hospital, Pharmacology-Genetic Laboratory gDepartment of Biostatistics and Medical Data Processing, INSERM-U717 hLaboratory for Epigenetics and Environment, Genotyping National Center, CEA, Genomic Institute iINSERM UMR-S 940, Paris, France. · Pubmed 24933605
  • Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Pharmacology-Genetics Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Dermatology Department, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 976, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Jean Dausset Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. · Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada. · INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. Electronic address: · Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. Electronic address: · Pubmed 24499734
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Affiliations of authors: INSERM, U976, Centre de Recherche sur la Peau, Hôpital Saint Louis , Paris , France (HHH, JA, SM, LM, VD, NBS, MB, AB, CL, ND, NS); AP-HP, Hôpital Bichat Claude Bernard, Département de Génétique , Paris , France (HHH, CK, AT, BG, NS); Université Paris Diderot, Sorbonne Paris Cité , UMRS976, Paris , France (HHH, CK, JA, LM, NBS, MB, AB, LD, AT, BG, ND, NS); Université Paris 6, INSERM UMRS975, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, AP-HP , Paris , France (SL, AB); INSERM, U940, Laboratoire de Pharmacologie, Hôpital Saint Louis Paris , France (SM); AP-HP, Hôpital Bichat Claude Bernard, Service de Dermatologie , Paris , France (VD); AP-HP, Hôpital Saint Louis, Service de Dermatologie , Paris , France (NBS, MB, CL, ND); INSERM, CRB3, Département de Pathologie, Hôpital Bichat, AP-HP , Paris , France (LD); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie , Boulogne Billancourt , France (PS); CHU Grenoble, Service de Dermatologie , Grenoble , France (MTL); Gustave Roussy, Service de Génétique, Département de Biopathologie , Villejuif , France (BBdP); Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580 , Heidelberg , Germany (RK); Department of Neurology, University Hospital of Würzburg , Würzburg , Germany (SK); Inserm UMR1037, Centre de Recherche en Cancérologie de Toulouse , Toulouse , France (NAA); Hôpital de l'Hôtel-Dieu, Service de Dermatologie , Lyon , France (LT); AP-HP, Groupe Pitié-Salpêtrière, Département de Génétique, Cytogénétique et Embryologie , Paris , France (AB). · Pubmed 26683220
2015
  • Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Université de Versailles St-Quentin, EA 4340, F-92104 Boulogne-Billancourt, France (PS, EFB); AP-HP, Hôpital Ambroise Paré, Service de Dermatologie Générale et Oncologique, F-92104 Boulogne-Billancourt, France (PS, EFB); Université de Versailles St-Quentin, UMR-S 1168, Saint Quentin-en-Yvelines, France (PA); INSERM, U1168 F-94807, Villejuif, France (PA); AP-HP, Hôpital Ambroise Paré, Unité de recherche clinique et département de santé Publique, F-92104 Boulogne-Billancourt, France (PA); APHP, service de Biochimie, Hôpital Saint-Louis, F-75010 Paris, France (DV); APHP, service de Dermatologie, Hôpital Saint-Louis, F-75010 Paris, France (CL); Université Paris Diderot, F-75010 Paris, France (CL, VD); APHP, service de Dermatologie, Hôpital Henri Mondor, F-94000 Créteil, France (PW); Université Paris-Est Créteil, F-94000 Créteil, France (PW); APHP, service de Dermatologie, Pavillon Tarnier, Hôpital Cochin, F-75014 Paris, France (ND, SA); Université Paris Descartes, F-75014 Paris, France (ND, SA); APHP, service de Dermatologie, Hôpital Bichat, F-75018 Paris, France (VD); Strathclyde Institute for Global Public Health at iPRI, F-69000 Lyon, France (PA, MB); International Prevention Research Institute (iPRI), F-69000 Lyon, France (PA, MD, MB). · Pubmed 26376687
  • aAPHP service de dermatologie bAPHP centre d'investigation clinique cAPHP Service de gastro-entérologie, hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris dUniversité Paris Diderot Paris 7, INSERM U976. · Pubmed 25464388
2010
  • Inserm, UMR-S 940 Laboratoire de Pharmacologie, Paris, France. · Pubmed 20824203
  • Department of Dermatology, Hôpital Saint Louis Assistance Publique-Hôpitaux Paris, University of Paris 7, INSERM U976, Paris, France. · Pubmed 20216240
Unspecified
2017
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
2016
  • Service de dermatologie, Hôpital saint Louis, 1 av Claude Vellefaux 75010 Paris, 0142385312. Electronic address: · Service de dermatologie, Hôpital saint Louis, 1 av Claude Vellefaux 75010 Paris, 0142385312. · Pubmed 28057176
2015
2014
2013
Miscellaneous institutions in Paris
2017
  • INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France. · Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France. · Département de dermatologie, AP-HP, Hôpital Saint Louis, Paris, France. · Département de Pathologie and INSERM U955 équipe 9, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Faculté de Médecine, Université Paris Est Créteil Val de Marne, Créteil, France. · Département de Pathologie, AP-HP, Hôpital Saint Louis, and INSERM U1165, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · AP-HP, Hôpital Saint Louis, Laboratoire de Pharmacologie, Paris, France. · Pubmed 28092671
2014
  • Laboratory for Functional Genomics, Fondation Jean Dausset - CEPH, 75010, Paris, France. · Pubmed 24969466
2012
  • Department of Dermatology, St-Louis Hospital, Paris, France. · Pubmed 22828248
2009
  • Unité Fonctionnelle Diagnostic Biologique Automatise, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7151, Paris, France. · Pubmed 19841396
St Louis University
2016
  • Kantar Health, Paris, France. · Amgen, Centre for Observational Research, Uxbridge, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. · APHP Dermatology and CIC Hospital Saint Louis University Paris 7, INSERM U976, Paris, France. · Department of Dermatology, University Hospital Duisburg-Essen, Essen, Germany. · Pubmed 27628317
2015
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Mater Hospital, Sydney, NSW, Australia. Electronic address: · Moscow City Oncology Hospital, Moscow, Russia. · Department of Medicine, University of Athens, Medical School, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Royal Marsden Hospital, London, UK. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, Hôpital Saint André, CHU Bordeaux, Bordeaux, France. · University Hospital Schleswig-Holstein, Kiel, Germany. · Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padua, Italy. · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Paris, France. · Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA, Australia. · Department of Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. · University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; German Cancer Research Center, Heidelberg, Germany. · Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Volograd Regional Oncology Dispensary #3, Volzhsky, Russia. · Elbe Klinikum Stade, Stade, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · University Hospital Essen, Essen, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Villejuif-Paris-Sud, France; Paris Sud University, Le Kremlin Bicêtre, France. · David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Merck & Co, Kenilworth, NJ, USA. · Massachusetts General Hospital Cancer Center, Boston MA, USA. · Pubmed 26037941
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Universitätsklinikum Essen, Hufelandstr. 55, Essen 45147, Germany. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Moscow City Oncology Hospital #62, Moscow 143423, Russia. Electronic address: · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. Electronic address: · University of Athens, Aghiou Thoma 17, Athens 11527, Greece. Electronic address: · Fondazione IRCCS Istituto Nazionale Tumori, via Giacomo Venezian, 1, Milan, Italy. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Sainte-Marguerite, 270 Boulevard de Sainte-Marguerite, Marseille 13009, France. Electronic address: · Dnepropetrovsk State Medical Academy, Dzerzhyns'koho Street 9, Dnepropetrovsk 49044, Ukraine. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Liebermeisterstraße 25, Tuebingen 72076, Germany. Electronic address: · APHP Dermatology CIC Hôpital Saint Louis, University Paris Diderot, INSERM U976, Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Royal Marsden Hospital, Fulham Road, London SW3 6JJ, United Kingdom. Electronic address: · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, via Gattamelata, 64, Padua 35128, Italy. Electronic address: · Sir Charles Gairdner Hospital, Hospital Avenue, Perth, WA 6009, Australia. Electronic address: · Hospital Clinic, Carrer Villarroel 170, Barcelona 08036, Spain. Electronic address: · Papa Giovanni XIII Hospital, Piazza OMS 1, Bergamo 24127, Italy. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston 02114, MA, United States. Electronic address: · Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN, United Kingdom. Electronic address: · David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles 90095, CA, United States. Electronic address: · Gustave Roussy and Paris 11 University, 114 Rue Edouard Vaillant, Villejuif-Paris-Sud 94805, France. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426, United States. Electronic address: · Melanoma Institute Australia & The University of Sydney, 40 Rocklands Road, Sydney 2060, Australia. Electronic address: · Pubmed 25794603
2014
  • Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, 375 Longwood Ave, Mailstop: MASCO 428, Boston, MA 02215, USA. Electronic address: · APHP Department of Dermatology, CIC, U976 Hôpital Saint-Louis University Paris Diderot, 1 Avenue Claude Vellefaux, Paris 75010, France. Electronic address: · Center for Immuno-Oncology, Melanoma Center, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena 53100, Italy. Electronic address: · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. Electronic address: · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: · Seattle Cancer Care Alliance, 825 Eastlake Ave E, G4-830, Seattle, WA 98109, USA. Electronic address: · Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: · Pubmed 25060490
  • Department of Dermatology, APHP, CIC, U976 Hôpital Saint-Louis University Paris Diderot, Paris, France · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Melanoma Therapeutics, Translational Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles. · Los Angeles Skin Cancer Institute at Beverly Hills Cancer Center, Beverly Hills. · Global Clinical Research. · Global Biometric Sciences, Bristol-Myers Squibb Company, Wallingford. · Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 25210016
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
97 Other Locations Show
Yearly article counts 0181519156936442